AvePoint, Inc. (AVPT) Guidance & Earnings Results
On 2026-08-06 AvePoint, Inc. raised guidance: "Full-year ARR guidance raised to $522.1M-$528.1M (26% YoY growth midpoint); Q3 revenue…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AVPTAvePoint, Inc.Follow AVPT — free
—
Price chart with a free account
- Market cap
- 3.5B
- P/E TTM
- 51.6
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 6 Aug 26 | Raised | Full-year ARR guidance raised to $522.1M-$528.1M (26% YoY growth midpoint); Q3 revenue $128.2M-$130.2M · full year |
| 7 May 26 | Raised | Full-year ARR guidance raised to $523.4M-$529.4M (26% YoY growth); revenue guidance $509.4M-$515.4M (22% YoY growth); non-GAAP operating income $91.5M-$94.5M · full year |
| 26 Feb 26 | Raised | 2026 ARR growth acceleration relative to 2025 (ex-Ydentic) · full year |
| 6 Nov 25 | Raised | FY2025 total revenue raised to $414.8M-$416.8M (from prior); non-GAAP operating income raised to $77.3M-$78.3M · full year |
| 7 Aug 25 | Raised | FY25 total revenue raised to $406.6-410.6M from prior guidance (not explicitly stated but implied by 'raising full-year guidance for all metrics'); FY25 ARR raised to $412.8-418.8M; FY25 non-GAAP operating income raised to $68.3-70.8M; Q3 2025 total revenue $104.6-106.6M; Q3 2025 non-GAAP operating income $18.0-19.0M · full year |
AvePoint, Inc. — questions
- What guidance did AvePoint, Inc. give?
- On 2026-08-06: "Full-year ARR guidance raised to $522.1M-$528.1M (26% YoY growth midpoint); Q3 revenue $128.2M-$130.2M"
- When does AvePoint, Inc. report earnings?
- AvePoint, Inc.'s next earnings report is expected on 2026-11-05.
Every figure on this page comes from AvePoint, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.